This is the authors' abstract. We don't add key points for this paper.
Distribution of CR and NANA metabolite levels in (A) Exploratory cohort and (B) Validation cohort adenocarcinoma cases. ****p<0.0001; LUAD, lung adenocarcinoma; x͂ = median
No takes yet. Share an insight, caveat, or question.
Dalal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: